Other languages Bioretec Oy

Equities

BRETEC

FI4000480454

Market Closed - Nasdaq Helsinki Other stock markets 12:00:00 2024-07-05 pm EDT			5-day change	1st Jan Change
2.77 ^EUR	-3.48%		-3.82%	+15.42%

Jun. 28	Bioretec Flags Delay in Receipt of European CE Mark for Trauma Screw	MT
Jun. 19	Bioretec Ltd. Reports Successful Clinical Outcomes from U.S. Controlled Launch of RemeOs Trauma Screw	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Bioretec Flags Delay in Receipt of European CE Mark for Trauma Screw	Jun. 28
Bioretec Ltd. Reports Successful Clinical Outcomes from U.S. Controlled Launch of RemeOs Trauma Screw	Jun. 19
Medical Device Company Bioretec Names New CEO	May. 21
Bioretec Ltd. Announces Transfer of Timo Lehtonen from CEO to Chief Technology Officer	May. 20
Bioretec Ltd Announces CEO Changes	May. 20
Bioretec Oy Announces Pekka Simula Not Available for Re-Election to Board of Directors	Apr. 05
Finland's Bioretec Gets US Patent Allowance for Magnesium Alloy Composition	Mar. 22
Bioretec Ltd. Receives a Patent by the U.S. Patent Office for its RemeOs Magnesium Alloy Composition	Mar. 21
Bioretec Secures US FDA Breakthrough Device Designation for Spinal Interbody Cage Implant	Mar. 14
Bioretec Has Been Granted FDA Breakthrough Device Designation Status for its RemeOs Spinal Interbody Cage	Mar. 14
Bioretec Expects EU Regulatory Approval for Trauma Screw in Q2	Mar. 11
Bioretec's European Market Authorization for RemeOs Trauma Screw Proceeded to Expert Panel Evaluation	Mar. 08
Bioretec Ltd Announces CEO Changes	Nov. 16
Bioretec Estimates the Approval of the European Market Authorization for the Biodegradable RemeOs? Trauma Screw Will Move to the First Quarter of 2024	23-10-18
Bioretec Ltd. Enters into the U.S. Distribution Agreement with Spartan Medical Inc. for the RemeOs Screws	23-09-12
Bioretec Ltd Unveils Its Revitalized Scientific Advisory Board	23-08-16
Bioretec Oy Appoints Esa Hallinen as Director of Operations and Member of the Management Team	23-07-14
Bioretec Ltd Acquires New CNC Machining Center to Increase Production Capacity of RemeOs Products at its Factory in Tampere, Finland	23-06-13
Bioretec Oy Approves Management Appointments	23-05-26
Bioretec Ltd Appoints Dr. Jeremy Dublon as Regulatory Advisor	23-05-16

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Bioretec Oy

Equities

BRETEC

FI4000480454

Other languages

Filters